Biomédecine translationnelle

  • ISSN: 2172-0479
  • Indice h du journal: 16
  • Note de citation du journal: 5.91
  • Facteur d’impact du journal: 3.66
Indexé dans
  • Ouvrir la porte J
  • Genamics JournalSeek
  • JournalTOCs
  • RechercheBible
  • Le facteur d'impact global (GIF)
  • Infrastructure nationale des connaissances en Chine (CNKI)
  • CiteFactor
  • Scimago
  • Bibliothèque des revues électroniques
  • Répertoire d'indexation des revues de recherche (DRJI)
  • OCLC - WorldCat
  • Invocation de Proquête
  • Publions
  • MIAR
  • Commission des bourses universitaires
  • Fondation genevoise pour la formation et la recherche médicales
  • Google Scholar
  • SHERPA ROMÉO
  • Laboratoires secrets des moteurs de recherche
  • ResearchGate
Partager cette page

Abstrait

The Occurrence of a High Number of Lung Cancer Metastases is Consonant with the Proposed Theory of Erythrocyte Associated Necrosis Factor

Wilson IB Onuigbo

In this journal, I argued that, concerning cancer necrosis itself, which was personally named as the Erythrocyte Associated Necrosis Factor (EANF), it plays a significant role. Accordingly, it is necessary to weigh repeatedly any evidence, which crops up or becomes recognized, in order to confirm or confute any such subsisting hypothesis. Elsewhere, it was hypothesized that EANF positively explains the anomalous lack of contralateral deposits in the cases of lung cancer. This emerged right from the experiences of the medical masters of yester years. In this context, another working hypothesis is being brought forward, namely, that when EANF production is low, the resulting metastases tend to be high in number. In conclusion, just as dangerous bleeding brought death in the days of yore, and the discovery of the Coagulation Factor brought relief, let EANF become the harbinger of the cure of cancer itself be it in the lung or elsewhere.